Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity

被引：7
|
作者：
Torras, J [1 ]
Figueras, J [1 ]
Lama, C [1 ]
Fabregat, J [1 ]
Ramos, E [1 ]
Rafecas, A [1 ]
Gil-Vernet, S [1 ]
Pares, D [1 ]
Busquets, J [1 ]
Jaurrieta, E [1 ]
机构：
[1] CSU Bellvitge, Liver Transplant Unit, Barcelona, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(99)00462-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2430 / 2430
页数：1
相关论文
共 50 条
  • [41] Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: Randomized, prospective, multicenter pilot study results
    Reich, DJ
    Clavien, PA
    Hodge, EE
    TRANSPLANTATION, 2005, 80 (01) : 18 - 25
  • [42] Pharmacokinetics of Mycophenolate Mofetil in heart transplant recipients
    Seebacher, G
    Mallinger, R
    Laufer, G
    Grimm, M
    Griesmacher, A
    Weigel, G
    Wolner, E
    Müller, MM
    PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 801 - 803
  • [43] Measurement of mycophenolate mofetil effect in transplant recipients
    Ogawa, N
    Nagashima, N
    Nakamura, M
    Shalabi, A
    Maley, WR
    Burdick, JF
    TRANSPLANTATION, 2001, 72 (03) : 422 - 427
  • [44] Tolerability of mycophenolate mofetil in organ transplant recipients
    Schweizer, RT
    Meisterling, LD
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2309 - 2309
  • [45] Preliminary experience with mycophenolate mofetil for preservation of renal function in cardiac transplant patients with documented cyclosporine nephrotoxicity
    Al-Aly, Z
    Sachdeva, A
    Ashley, JMP
    Bastani, B
    NEPHROLOGY, 2006, 11 (02) : 151 - 155
  • [46] Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients
    Kornberg, A.
    Kuepper, B.
    Wilberg, J.
    Tannapfel, A.
    Thrum, K.
    Baerthel, E.
    Hommann, M.
    Settmacher, U.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (04) : 295 - 301
  • [47] Mycophenolate Mofetil Hepatotoxicity Associated With Mitochondrial Abnormality in Liver Transplant Recipients and Mice
    Warren, Mikako
    Mitsinikos, Tania
    Yanni, George
    Sasaki, Mika
    Sasaki, Atsuo T.
    Thomas, Dan
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (04): : 463 - 470
  • [48] Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
    Thervet, E
    Morelon, E
    Ducloux, D
    Bererhi, L
    Noël, LH
    Bedrossian, JJ
    Puget, S
    Chalopin, JM
    Mihatsch, M
    Legendre, C
    Kreis, H
    CLINICAL TRANSPLANTATION, 2000, 14 (06) : 561 - 566
  • [49] Conversion of cyclosporine (neoral;: CsA) to mycophenolate mofetil (MMF) in stable renal transplant recipients.
    Schrama, YC
    Hené, RJ
    Boer, P
    Koomans, HA
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1625 - 1626
  • [50] Outcome of Mycophenolate Mofetil Intolerant Liver Transplant Recipients: Hangzhou Experience.
    Xie, Qinfen
    Xu, Xiao
    Zheng, Shusen
    LIVER TRANSPLANTATION, 2011, 17 (06) : S152 - S153
12345